Source:
Terre Haute Tribune-StarA bill to make an over-the-counter cold medicine once again available by prescription-only has been introduced to the Indiana General Assembly by Sen. Tim Skinner, but it could be a tough battle just to get the bill heard in committee.
Senate Bill 474 is a measure that would make materials, compounds, mixtures and preparations that contain ephedrine or pseudoephedrine available by prescription only. Ephedrine and pseudoephedrine — or PSE — are known as precursor drugs used in the production of methamphetamine.
Skinner (D-Terre Haute) has been outspoken on the need for statewide action to limit the public’s access to the popular decongestant. And lately he has been trying to convince fellow legislators that prescription-only access to PSE is the best way to win the battle against meth production. So far, however, it has been a hard sell.
... The fiscal impact statement for SB 474 states that the Indiana Professional Licensing Agency and Board of Pharmacy Expenditures have estimated a cost of $127,000 to put ephedrine and pseudoephedrine on the controlled substance list, due to data collection and reporting requirements. The state would also incur about $24,000 annually in Medicaid claims due to the change.
Read more:
http://tribstar.com/news/x1221298391/Skinner-Meth-bill-may-be-tough-sell